|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2006-10-25
|
|
pubmed:abstractText |
The multiple organ dysfunction syndrome (MODS) is the sequential failure of several organ systems after a trigger event, such as sepsis, pneumonia or cardiogenic shock. Even today, mortality is high. Statin therapy is associated with reduction of inflammation and subsequent rates of severe sepsis and ICU admission of patients admitted to hospital with presumed or documented acute bacterial infection. Our study aimed to characterize a potential survival benefit by statin therapy in MODS patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0342-4642
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1248-51
|
|
pubmed:meshHeading |
pubmed-meshheading:16788803-Cohort Studies,
pubmed-meshheading:16788803-Female,
pubmed-meshheading:16788803-Heptanoic Acids,
pubmed-meshheading:16788803-Humans,
pubmed-meshheading:16788803-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16788803-Male,
pubmed-meshheading:16788803-Middle Aged,
pubmed-meshheading:16788803-Multiple Organ Failure,
pubmed-meshheading:16788803-Pravastatin,
pubmed-meshheading:16788803-Pyrroles,
pubmed-meshheading:16788803-Retrospective Studies,
pubmed-meshheading:16788803-Simvastatin,
pubmed-meshheading:16788803-Survival Rate
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome.
|
|
pubmed:affiliation |
Department of Medicine III, Martin Luther University Halle-Wittenberg, Klinikum Kröllwitz, Ernst-Grube-Strasse 40, 06097 Halle/Saale, Germany. hendrik.schmidt@medizin.uni-halle.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
